Similarly, Donafenib induces oxidative stress in HCC cells by increasing mROS, decreasing GPx activity, and suppressing Mn-SOD, ultimately reducing mitochondrial membrane potential, COX IV activity, and ATP levels [31]. The gene discussed is SOD2; the disease is hepatocellular carcinoma.